Skip to content
healthcare.dev
Get a free key

RECOMBIVAX HB

NDC 0006-4094, Hepatitis B Vaccine (Recombinant), injection, suspension, from Merck Sharp & Dohme LLC.

Product NDC
0006-4094
Status
Listed
Labeler
Merck Sharp & Dohme LLC
Dosage form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR, SUBCUTANEOUS
Product type
VACCINE
Marketing category
BLA
Application
BLA101066
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0006-4094 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN10 ug/mL

Pharmacologic classes

Actively Acquired Immunity [PE]; Hepatitis B Vaccines [CS]; Inactivated Hepatitis B Virus Vaccine [EPC]; Vaccines, Inactivated [CS]

Package NDCNDC-11Package
0006-4094-020000640940210 SYRINGE in 1 CARTON (0006-4094-02) / 1 mL in 1 SYRINGE (0006-4094-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 0006-4094 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0006-4094 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0006-4094. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.